In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Stoke Therapeutics Inc (NASDAQ: STOK) closed at $8.87 in the last session, down -1.44% from day before closing price of $9.00. In other words, the price has decreased by -$1.44 from its previous closing price. On the day, 1.63 million shares were traded. STOK stock price reached its highest trading level at $8.93 during the session, while it also had its lowest trading level at $7.705.
Ratios:
We take a closer look at STOK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.09. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on December 20, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 23 ’24 when Skorpios Trust sold 2,000,000 shares for $11.50 per share. The transaction valued at 23,000,000 led to the insider holds 6,906,181 shares of the business.
Blue Horizon Enterprise Ltd bought 2,000,000 shares of STOK for $23,180,000 on Dec 23 ’24. On Dec 09 ’24, another insider, Ticho Barry, who serves as the CHIEF MEDICAL OFFICER of the company, sold 2,586 shares for $12.99 each. As a result, the insider received 33,596 and left with 44,746 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STOK now has a Market Capitalization of 469817280 and an Enterprise Value of 242808800. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.07 while its Price-to-Book (P/B) ratio in mrq is 2.02. Its current Enterprise Value per Revenue stands at 14.502 whereas that against EBITDA is -2.111.
Stock Price History:
The Beta on a monthly basis for STOK is 0.95, which has changed by 0.48080134 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, STOK has reached a high of $17.58, while it has fallen to a 52-week low of $5.60. The 50-Day Moving Average of the stock is -7.35%, while the 200-Day Moving Average is calculated to be -28.99%.
Shares Statistics:
According to the various share statistics, STOK traded on average about 805.70K shares per day over the past 3-months and 716930 shares per day over the past 10 days. A total of 52.94M shares are outstanding, with a floating share count of 40.86M. Insiders hold about 22.86% of the company’s shares, while institutions hold 91.67% stake in the company. Shares short for STOK as of 1740700800 were 11174208 with a Short Ratio of 13.87, compared to 1738281600 on 8985955. Therefore, it implies a Short% of Shares Outstanding of 11174208 and a Short% of Float of 31.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
